Evaluating Targeted Therapy for People With Advanced Gastric or Gastroesophageal Junction Cancer: The ASCO Plenary Series
Read research from the March 2023 session of the ASCO Plenary Series, which highlights a study evaluating a new targeted therapy drug given in combination with chemotherapy for people with advanced gastric or gastroesophageal junction cancer.